Back to Search Start Over

B-cell receptor pathway inhibitors affect CD20 levels and impair antitumor activity of anti-CD20 monoclonal antibodies.

Authors :
Bojarczuk K
Siernicka M
Dwojak M
Bobrowicz M
Pyrzynska B
Gaj P
Karp M
Giannopoulos K
Efremov DG
Fauriat C
Golab J
Winiarska M
Source :
Leukemia [Leukemia] 2014 May; Vol. 28 (5), pp. 1163-7. Date of Electronic Publication: 2014 Jan 10.
Publication Year :
2014

Details

Language :
English
ISSN :
1476-5551
Volume :
28
Issue :
5
Database :
MEDLINE
Journal :
Leukemia
Publication Type :
Report
Accession number :
24492323
Full Text :
https://doi.org/10.1038/leu.2014.12